BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Vugt JL, Levolger S, de Bruin RW, van Rosmalen J, Metselaar HJ, IJzermans JN. Systematic Review and Meta-Analysis of the Impact of Computed Tomography-Assessed Skeletal Muscle Mass on Outcome in Patients Awaiting or Undergoing Liver Transplantation. Am J Transplant 2016;16:2277-92. [PMID: 26813115 DOI: 10.1111/ajt.13732] [Cited by in Crossref: 196] [Cited by in F6Publishing: 181] [Article Influence: 32.7] [Reference Citation Analysis]
Number Citing Articles
1 Haj Ali S, Abu Sneineh A, Hasweh R. Nutritional assessment in patients with liver cirrhosis. World J Hepatol 2022; 14(9): 1694-1703 [DOI: 10.4254/wjh.v14.i9.1694] [Reference Citation Analysis]
2 Lortie J, Gage G, Rush B, Heymsfield SB, Szczykutowicz TP, Kuchnia AJ. The effect of computed tomography parameters on sarcopenia and myosteatosis assessment: a scoping review. J Cachexia Sarcopenia Muscle 2022. [PMID: 36065509 DOI: 10.1002/jcsm.13068] [Reference Citation Analysis]
3 Johnston HE, Takefala TG, Kelly JT, Keating SE, Coombes JS, Macdonald GA, Hickman IJ, Mayr HL. The Effect of Diet and Exercise Interventions on Body Composition in Liver Cirrhosis: A Systematic Review. Nutrients 2022;14:3365. [DOI: 10.3390/nu14163365] [Reference Citation Analysis]
4 Beumer BR, van Vugt JL, Sapisochin G, Yoon P, Bongini M, Lu D, Xu X, De Simone P, Pintore L, Golse N, Nowosad M, Bennet W, Tsochatzis E, Koutli E, Abbassi F, Claasen MP, Merli M, O'rourke J, Gambato M, Benito A, Majumdar A, Tan EK, Ebadi M, Montano‐loza AJ, Berenguer M, Metselaar HJ, Polak WG, Mazzaferro V, Ijzermans JN, Haider MA, Salinas‐miranda E, Bhoori S, Rossi P, Remiszewski P, Korzeniowski K, Arico F, Toso C, Ferri F, Shah T, Puchades L, Herreras J, De Man RA, Van Klaveren D; Collaborators. Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria. J cachexia sarcopenia muscle. [DOI: 10.1002/jcsm.13053] [Reference Citation Analysis]
5 Peng H, Zhang Q, Luo L, Lei S, Xiong T, Long L, Xiong Y, Zhang L, Zheng J, Luo X. A prognostic model of acute-on-chronic liver failure based on sarcopenia. Hepatol Int 2022. [PMID: 35771410 DOI: 10.1007/s12072-022-10363-2] [Reference Citation Analysis]
6 Hey P, Hoermann R, Gow P, Hanrahan TP, Testro AG, Apostolov R, Sinclair M. Reduced upper limb lean mass on dual energy X-ray absorptiometry predicts adverse outcomes in male liver transplant recipients. World J Transplant 2022; 12(6): 120-130 [DOI: 10.5500/wjt.v12.i6.120] [Reference Citation Analysis]
7 De Marco D, Mamane S, Choo W, Mullie L, Xue X, Afilalo M, Afilalo J. Muscle Area and Density Assessed by Abdominal Computed Tomography in Healthy Adults: Effect of Normal Aging and Derivation of Reference Values. J Nutr Health Aging 2022;26:243-6. [PMID: 35297466 DOI: 10.1007/s12603-022-1746-3] [Reference Citation Analysis]
8 Artru F, Vietti-violi N, Sempoux C, Barbosa J, Becce F, Sah N, Marot A, Deltenre P, Moschouri E, Fraga M, Hocquelet A, Duran R, Moradpour D, Rautou P, Denys A. Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100511] [Reference Citation Analysis]
9 Marta H, Elba L, Lucía G, Santiago B, Luis R, Carlos FC, Christie P, Marta L, Luis MJ, Natalia F, Enrique VDB, Ana R, Luis CJ. A NOMOGRAM AS AN INDIRECT METHOD TO IDENTIFY SARCOPENIA IN PATIENTS WITH LIVER CIRRHOSIS. Annals of Hepatology 2022. [DOI: 10.1016/j.aohep.2022.100723] [Reference Citation Analysis]
10 Aller de la Fuente R. Nutrition and Chronic Liver Disease. Clin Drug Investig 2022. [PMID: 35484325 DOI: 10.1007/s40261-022-01141-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Luengpradidgun L, Chamroonkul N, Sripongpun P, Kaewdech A, Tanutit P, Ina N, Piratvisuth T. Utility of handgrip strength (HGS) and bioelectrical impedance analysis (BIA) in the diagnosis of sarcopenia in cirrhotic patients. BMC Gastroenterol 2022;22:159. [PMID: 35354434 DOI: 10.1186/s12876-022-02236-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Allen SL, Seabright AP, Quinlan JI, Dhaliwal A, Williams FR, Fine NHF, Hodson DJ, Armstrong MJ, Elsharkaway AM, Greig CA, Lai Y, Lord JM, Lavery GG, Breen L. The Effect of Ex Vivo Human Serum from Liver Disease Patients on Cellular Protein Synthesis and Growth. Cells 2022;11:1098. [DOI: 10.3390/cells11071098] [Reference Citation Analysis]
13 Liu J, Ma J, Yang C, Chen M, Shi Q, Zhou C, Huang S, Chen Y, Wang Y, Li T, Xiong B. Sarcopenia in Patients with Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Placement. Radiology 2022;:211172. [PMID: 35289658 DOI: 10.1148/radiol.211172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Mauro E, Diaz JM, Garcia-Olveira L, Spina JC, Savluk L, Zalazar F, Saidman J, De Santibañes M, Pekolj J, De Santibañes E, Crespo G, Abraldes JG, Gadano A. Sarcopenia HIBA score predicts sarcopenia and mortality in patients on the liver transplant waiting list. Hepatol Commun 2022. [PMID: 35238487 DOI: 10.1002/hep4.1919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Raghu VK, Sico R, Rudolph JA, Mazariegos GV, Squires J, Squires JE. Sarcopenia prevalence in pediatric intestinal transplant recipients: Implications on post‐transplant outcomes. Pediatric Transplantation. [DOI: 10.1111/petr.14256] [Reference Citation Analysis]
16 Cho HJ, Hwang Y, Yang S, Kim M. CT anthropometric analysis of the prognosis of traumatic brain injury: A retrospective study to compare between psoas muscle and abdominal skeletal muscle. Injury 2022. [DOI: 10.1016/j.injury.2022.02.043] [Reference Citation Analysis]
17 Menozzi R, Valoriani F, Prampolini F, Banchelli F, Boldrini E, Martelli F, Galetti S, Fari' R, Gabriele S, Palumbo P, Forni D, Pantaleoni M, D'Amico R, Pecchi AR. Impact of sarcopenia in SARS-CoV-2 patients during two different epidemic waves. Clin Nutr ESPEN 2022;47:252-9. [PMID: 35063210 DOI: 10.1016/j.clnesp.2021.12.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
18 Romano A, Triarico S, Rinninella E, Natale L, Brizi MG, Cintoni M, Raoul P, Maurizi P, Attinà G, Mastrangelo S, Gasbarrini A, Mele MC, Ruggiero A. Clinical Impact of Nutritional Status and Sarcopenia in Pediatric Patients with Bone and Soft Tissue Sarcomas: A Pilot Retrospective Study (SarcoPed). Nutrients 2022;14:383. [PMID: 35057564 DOI: 10.3390/nu14020383] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
19 Zhang B, Cai W, Gao F, Lin X, Qian T, Gu K, Song B, Chen T. Prediction of Patient Survival with Psoas Muscle Density Following Transjugular Intrahepatic Portosystemic Shunts: A Retrospective Cohort Study. Med Sci Monit 2022;28:e934057. [PMID: 35031594 DOI: 10.12659/MSM.934057] [Reference Citation Analysis]
20 Duong F, Gadermayr M, Merhof D, Kuhl C, Bruners P, Loosen SH, Roderburg C, Truhn D, Schulze-Hagen MF. Automated major psoas muscle volumetry in computed tomography using machine learning algorithms. Int J Comput Assist Radiol Surg 2021. [PMID: 34928445 DOI: 10.1007/s11548-021-02539-2] [Reference Citation Analysis]
21 Tantai X, Liu Y, Yeo YH, Praktiknjo M, Mauro E, Hamaguchi Y, Engelmann C, Zhang P, Jeong JY, van Vugt JLA, Xiao H, Deng H, Gao X, Ye Q, Zhang J, Yang L, Cai Y, Liu Y, Liu N, Li Z, Han T, Kaido T, Sohn JH, Strassburg C, Berg T, Trebicka J, Hsu YC, IJzermans JNM, Wang J, Su GL, Ji F, Nguyen MH. Effect of sarcopenia on survival in patients with cirrhosis: A systematic review and meta-analysis. J Hepatol 2021:S0168-8278(21)02174-7. [PMID: 34785325 DOI: 10.1016/j.jhep.2021.11.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 16.0] [Reference Citation Analysis]
22 Mihai F, Trifan A, Stanciu C, Huiban L, Muzîca C, Lupașcu-Ursulescu C, Negru D, Savin ML, Gîrleanu I, Cuciureanu T, Sîngeap AM. L3 Skeletal Muscle Index Dynamics in Patients with HCV-Related Compensated Cirrhosis Following Sustained Virological Response after Direct Acting Antiviral Treatment. Medicina (Kaunas) 2021;57:1226. [PMID: 34833444 DOI: 10.3390/medicina57111226] [Reference Citation Analysis]
23 Chong J, Guorgui J, Coy H, Ito T, Lu M, DiNorcia J, Agopian VG, Farmer DG, Raman SS, Busuttil RW, Kaldas FM. Perioperative Skeletal Muscle Fluctuations in High-Acuity Liver Transplantation. J Surg Res 2021;270:386-93. [PMID: 34739998 DOI: 10.1016/j.jss.2021.09.030] [Reference Citation Analysis]
24 Tsao YT, Lee WC, Huang CH, Lin IH, Huang YY. A comprehensive investigation of nutritional status and psoas muscle mass in predicting five-year survival in patients with liver transplant. J Formos Med Assoc 2021:S0929-6646(21)00461-7. [PMID: 34666924 DOI: 10.1016/j.jfma.2021.09.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Ito T, Guorgui J, Markovic D, Coy H, Younan SM, DiNorcia J 3rd, Agopian VG, Farmer DG, Raman SS, Busuttil RW, Kaldas FM. Sarcopenia in high acuity liver transplantation: Does it predict outcomes? Clin Transplant 2021;:e14503. [PMID: 34634157 DOI: 10.1111/ctr.14503] [Reference Citation Analysis]
26 Zeng X, Shi ZW, Yu JJ, Wang LF, Luo YY, Jin SM, Zhang LY, Tan W, Shi PM, Yu H, Zhang CQ, Xie WF. Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China. J Cachexia Sarcopenia Muscle 2021;12:1948-58. [PMID: 34520115 DOI: 10.1002/jcsm.12797] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
27 Ritz A, Froeba-Pohl A, Kolorz J, Vigodski V, Hubertus J, Ley-Zaporozhan J, von Schweinitz D, Häberle B, Schmid I, Kappler R, Lurz E, Berger M. Total Psoas Muscle Area as a Marker for Sarcopenia Is Related to Outcome in Children With Neuroblastoma. Front Surg 2021;8:718184. [PMID: 34490339 DOI: 10.3389/fsurg.2021.718184] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
28 Lai JC, Tandon P, Bernal W, Tapper EB, Ekong U, Dasarathy S, Carey EJ. Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;74:1611-44. [PMID: 34233031 DOI: 10.1002/hep.32049] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 39.0] [Reference Citation Analysis]
29 Puchades Renau L, Herreras López J, Cebrià I Iranzo MÀ, Cezón Serrano N, Di Maira T, Berenguer M. Frailty and Sarcopenia in Acute-on-Chronic Liver Failure. Hepatol Commun 2021;5:1333-47. [PMID: 34430779 DOI: 10.1002/hep4.1722] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Parajuli S, Aziz F, Garg N, Wallschlaeger RE, Lorden HM, Al-Qaoud T, Mandelbrot DA, Odorico AJS. Frailty in Pancreas Transplantation. Transplantation 2021;105:1685-94. [PMID: 33606487 DOI: 10.1097/TP.0000000000003586] [Reference Citation Analysis]
31 Kaur N, Emamaullee J, Lian T, Lo M, Ender P, Kahn J, Sher L. Impact of Morbid Obesity on Liver Transplant Candidacy and Outcomes: National and Regional Trends. Transplantation 2021;105:1052-60. [PMID: 33741845 DOI: 10.1097/TP.0000000000003404] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
32 Miarka M, Gibiński K, Janik MK, Główczyńska R, Zając K, Pacho R, Raszeja-Wyszomirska J. Sarcopenia-The Impact on Physical Capacity of Liver Transplant Patients. Life (Basel) 2021;11:740. [PMID: 34440484 DOI: 10.3390/life11080740] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Weiss E, Giabicani M, Saner F. Do Liver Transplantation Criteria Differ According to the Type of Donor and the Severity of the Recipient? Transplantation 2021;105:e32. [PMID: 33617205 DOI: 10.1097/TP.0000000000003563] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Lenchik L, Barnard R, Boutin RD, Kritchevsky SB, Chen H, Tan J, Cawthon PM, Weaver AA, Hsu FC. Automated Muscle Measurement on Chest CT Predicts All-Cause Mortality in Older Adults From the National Lung Screening Trial. J Gerontol A Biol Sci Med Sci 2021;76:277-85. [PMID: 32504466 DOI: 10.1093/gerona/glaa141] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
35 Pinto Dos Santos D, Kloeckner R, Koch S, Hoppe-Lotichius M, Zöller D, Toenges G, Kremer WM, Zimmermann T, Mittler J, Lang H, Düber C, Galle PR, Weinmann A, Sprinzl MF. Sarcopenia as prognostic factor for survival after orthotopic liver transplantation. Eur J Gastroenterol Hepatol 2020;32:626-34. [PMID: 31725030 DOI: 10.1097/MEG.0000000000001552] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
36 Wackenthaler A, Molière S, Artzner T, Michard B, Schenck M, Addeo P, Besch C, Bachellier P, Schneider F, Veillon F, Faitot F. Pre-operative CT scan helps predict outcome after liver transplantation for acute-on-chronic grade 3 liver failure. Eur Radiol 2021. [PMID: 34173847 DOI: 10.1007/s00330-021-08131-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Boster JM, Browne LP, Pan Z, Zhou W, Ehrlich PF, Sundaram SS. Higher Mortality in Pediatric Liver Transplant Candidates With Sarcopenia. Liver Transpl 2021;27:808-17. [PMID: 33621376 DOI: 10.1002/lt.26027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
38 Li T, Xu M, Kong M, Song W, Duan Z, Chen Y. Use of skeletal muscle index as a predictor of short-term mortality in patients with acute-on-chronic liver failure. Sci Rep 2021;11:12593. [PMID: 34131260 DOI: 10.1038/s41598-021-92087-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Verhagen MV, Levolger S, Hulshoff JB, Werner MJM, van der Doef HPJ, Viddeleer AR, de Kleine RH, de Haas RJ. Utility of Preoperative Computed Tomography-Based Body Metrics in Relation to Postoperative Complications in Pediatric Liver Transplantation Recipients. Liver Transpl 2021. [PMID: 34118133 DOI: 10.1002/lt.26205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Woodward AJ, Wallen MP, Ryan J, Ward LC, Coombes JS, Macdonald GA. Evaluation of techniques used to assess skeletal muscle quantity in patients with cirrhosis. Clin Nutr ESPEN 2021;44:287-96. [PMID: 34330481 DOI: 10.1016/j.clnesp.2021.05.029] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Ruby L, Sanabria SJ, Saltybaeva N, Frauenfelder T, Alkadhi H, Rominger MB. Comparison of ultrasound speed-of-sound of the lower extremity and lumbar muscle assessed with computed tomography for muscle loss assessment. Medicine (Baltimore) 2021;100:e25947. [PMID: 34032704 DOI: 10.1097/MD.0000000000025947] [Reference Citation Analysis]
42 Bertuzzo VR, Renzulli M, Clemente A, Cucchetti A, Maroni L, Frascaroli G, Pellegrini S, Dajti E, Spinelli D, Peta G, Maria Ierardi A, Carrafiello G, Strigari L, Colecchia A, Golfieri R, Pinna AD, Ravaioli M, Cescon M. Pre-transplant Psoas Muscle Density as a Ready-to-Use and Low-cost Predictor of Patient Survival After Liver Transplant. Hepat Mon 2021;21. [DOI: 10.5812/hepatmon.99690] [Reference Citation Analysis]
43 Cañamares-Orbis P, Bernal-Monterde V, Sierra-Gabarda O, Casas-Deza D, Garcia-Rayado G, Cortes L, Lué A. Impact of Liver and Pancreas Diseases on Nutritional Status. Nutrients 2021;13:1650. [PMID: 34068295 DOI: 10.3390/nu13051650] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
44 Amarasinghe KC, Lopes J, Beraldo J, Kiss N, Bucknell N, Everitt S, Jackson P, Litchfield C, Denehy L, Blyth BJ, Siva S, MacManus M, Ball D, Li J, Hardcastle N. A Deep Learning Model to Automate Skeletal Muscle Area Measurement on Computed Tomography Images. Front Oncol 2021;11:580806. [PMID: 34026597 DOI: 10.3389/fonc.2021.580806] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
45 Zelber-Sagi S, Ivancovsky-Wajcman D, Rabinowich L, Bentov I, Deutsch L. Nutritional Evaluation and Treatment of the Cirrhotic Patient. Clin Liver Dis 2021;25:373-92. [PMID: 33838856 DOI: 10.1016/j.cld.2021.01.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Lai Q, Magistri P, Lionetti R, Avolio AW, Lenci I, Giannelli V, Pecchi A, Ferri F, Marrone G, Angelico M, Milana M, Schinniná V, Menozzi R, Di Martino M, Grieco A, Manzia TM, Tisone G, Agnes S, Rossi M, Di Benedetto F, Ettorre GM; Sarco-Model Study Group. Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation. Liver Int 2021;41:1629-40. [PMID: 33793054 DOI: 10.1111/liv.14889] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
47 Habig G, Smaltz C, Halegoua-DeMarzio D. Presence and Implications of Sarcopenia in Non-alcoholic Steatohepatitis. Metabolites 2021;11:242. [PMID: 33920751 DOI: 10.3390/metabo11040242] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
48 Runkel M, Diallo TD, Lang SA, Bamberg F, Benndorf M, Fichtner-Feigl S. The Role of Visceral Obesity, Sarcopenia and Sarcopenic Obesity on Surgical Outcomes After Liver Resections for Colorectal Metastases. World J Surg 2021;45:2218-26. [PMID: 33842995 DOI: 10.1007/s00268-021-06073-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
49 Mazzola A, Brustia R, Magro B, Atif M, Ouali N, Tourret J, Barrou B, Scatton O, Conti F. Impact of sarcopenia on clinical outcomes of patients undergoing simultaneous liver and kidney transplantation: a cohort study. Clin Res Hepatol Gastroenterol 2021;45:101692. [PMID: 33848672 DOI: 10.1016/j.clinre.2021.101692] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
50 Whitsett M, Serper M. Exercise Interventions for Transplant Recipients. Curr Transpl Rep 2021;8:111-7. [DOI: 10.1007/s40472-021-00324-3] [Reference Citation Analysis]
51 Ohashi K, Ishikawa T, Hoshii A, Hokari T, Noguchi H, Suzuki M, Hirosawa H, Imai M, Mitobe Y, Yoshida T. Optimal Skeletal Muscle Mass Index Cut-Off Values for Presarcopenia Evaluated by Computed Tomography against Dual-Energy X-ray Absorptiometry in Patients with Chronic Liver Disease. J Clin Med 2021;10:1419. [PMID: 33915929 DOI: 10.3390/jcm10071419] [Reference Citation Analysis]
52 Nishikawa H, Yoh K, Enomoto H, Nishimura T, Nishiguchi S, Iijima H. Combined grip strength and calf circumference as a useful prognostic system in patients with liver diseases: a large cohort study. Ann Transl Med 2021;9:624. [PMID: 33987322 DOI: 10.21037/atm-20-6901] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Kim Y. Emerging Treatment Options for Sarcopenia in Chronic Liver Disease. Life (Basel) 2021;11:250. [PMID: 33803020 DOI: 10.3390/life11030250] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
54 Eriksen CS, Kimer N, Suetta C, Møller S. Arm lean mass determined by dual-energy X-ray absorptiometry is superior to characterize skeletal muscle and predict sarcopenia-related mortality in cirrhosis. Am J Physiol Gastrointest Liver Physiol 2021;320:G729-40. [PMID: 33729006 DOI: 10.1152/ajpgi.00478.2020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
55 Li GH, Lee GK, Au PC, Chan M, Li HL, Cheung BM, Wong IC, Lee VH, Mok J, Yip BH, Cheng KK, Wu CH, Cheung CL. The effect of different measurement modalities in the association of lean mass with mortality: A systematic review and meta-analysis. Osteoporos Sarcopenia 2021;7:S13-8. [PMID: 33997304 DOI: 10.1016/j.afos.2021.02.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
56 Portincasa P, Di Ciaula A, Wang DQ. Longer Walking Distance, More Fat, Better Survival: Prognostic Indicators of Liver Cirrhosis. J Gastrointestin Liver Dis 2021;30:8-12. [PMID: 33723545 DOI: 10.15403/jgld-3455] [Reference Citation Analysis]
57 Koon-Yee Lee G, Chun-Ming Au P, Hoi-Yee Li G, Chan M, Li HL, Man-Yung Cheung B, Chi-Kei Wong I, Ho-Fun Lee V, Mok J, Hon-Kei Yip B, King-Yip Cheng K, Wu CH, Cheung CL. Sarcopenia and mortality in different clinical conditions: A meta-analysis. Osteoporos Sarcopenia 2021;7:S19-27. [PMID: 33997305 DOI: 10.1016/j.afos.2021.02.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
58 Sciarrone SS, Zanetto A, Russo FP, Germani G, Gambato M, Battistella S, Pellone M, Shalaby S, Burra P, Senzolo M. Malnourished cirrhotic patient: what should we do? Minerva Gastroenterol (Torino) 2021;67:11-22. [PMID: 33784807 DOI: 10.23736/S2724-5985.20.02776-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Williams FR, Milliken D, Lai JC, Armstrong MJ. Assessment of the Frail Patient With End-Stage Liver Disease: A Practical Overview of Sarcopenia, Physical Function, and Disability. Hepatol Commun 2021;5:923-37. [PMID: 34141980 DOI: 10.1002/hep4.1688] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
60 Orman ES, Johnson AW, Ghabril M, Sachs GA. Hospice care for end stage liver disease in the United States. Expert Rev Gastroenterol Hepatol 2021;15:797-809. [PMID: 33599185 DOI: 10.1080/17474124.2021.1892487] [Reference Citation Analysis]
61 Bot D, Droop A, Lucassen CJ, van Veen ME, van Vugt JLA, Shahbazi Feshtali S, Leistra E, Tushuizen ME, van Hoek B. Both muscle quantity and quality are predictors of waiting list mortality in patients with end-stage liver disease. Clin Nutr ESPEN 2021;42:272-9. [PMID: 33745592 DOI: 10.1016/j.clnesp.2021.01.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
62 Hey P, Gow P, Testro AG, Apostolov R, Chapman B, Sinclair M. Nutraceuticals for the treatment of sarcopenia in chronic liver disease. Clin Nutr ESPEN 2021;41:13-22. [PMID: 33487256 DOI: 10.1016/j.clnesp.2020.11.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
63 Derstine BA, Holcombe SA, Ross BE, Wang NC, Su GL, Wang SC. Optimal body size adjustment of L3 CT skeletal muscle area for sarcopenia assessment. Sci Rep 2021;11:279. [PMID: 33431971 DOI: 10.1038/s41598-020-79471-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
64 Paternostro R, Bardach C, Hofer BS, Scheiner B, Schwabl P, Asenbaum U, Ba-Ssalamah A, Scharitzer M, Bucscis T, Simbrunner B, Bauer D, Trauner M, Mandorfer M, Reiberger T, Lampichler K. Prognostic impact of sarcopenia in cirrhotic patients stratified by different severity of portal hypertension. Liver Int. 2021;41:799-809. [PMID: 33290614 DOI: 10.1111/liv.14758] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
65 Johnston HE, de Crom T, Hargrave C, Adhyaru P, Woodward AJ, Pang S, Ali A, Coombes JS, Keating SE, McLean K, Mayr HL, Macdonald GA, Hickman IJ. The inter- and intrarater reliability and feasibility of dietetic assessment of sarcopenia and frailty in potential liver transplant recipients: A mixed-methods study. Clin Transplant 2021;35:e14185. [PMID: 33306855 DOI: 10.1111/ctr.14185] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Takeda M, Sakamoto S, Uchida H, Shimizu S, Yanagi Y, Fukuda A, Nosaka S, Kasahara M. Impact of sarcopenia in infants with liver transplantation for biliary atresia. Pediatr Transplant 2021;25:e13950. [PMID: 33326674 DOI: 10.1111/petr.13950] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
67 Hegyi PJ, Soós A, Hegyi P, Szakács Z, Hanák L, Váncsa S, Ocskay K, Pétervári E, Balaskó M, Eröss B, Pár G. Pre-transplant Sarcopenic Obesity Worsens the Survival After Liver Transplantation: A Meta-Analysis and a Systematic Review. Front Med (Lausanne) 2020;7:599434. [PMID: 33392221 DOI: 10.3389/fmed.2020.599434] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
68 Kulkarni AV, Arab JP, Premkumar M, Benítez C, Tirumalige Ravikumar S, Kumar P, Sharma M, Reddy DN, Simonetto DA, Rao PN. Terlipressin has stood the test of time: Clinical overview in 2020 and future perspectives. Liver Int 2020;40:2888-905. [DOI: 10.1111/liv.14703] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
69 Harhay MN, Rao MK, Woodside KJ, Johansen KL, Lentine KL, Tullius SG, Parsons RF, Alhamad T, Berger J, Cheng XS, Lappin J, Lynch R, Parajuli S, Tan JC, Segev DL, Kaplan B, Kobashigawa J, Dadhania DM, McAdams-DeMarco MA. An overview of frailty in kidney transplantation: measurement, management and future considerations. Nephrol Dial Transplant 2020;35:1099-112. [PMID: 32191296 DOI: 10.1093/ndt/gfaa016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
70 Marasco G, Dajti E, Ravaioli F, Brocchi S, Rossini B, Alemanni LV, Peta G, Bartalena L, Golfieri R, Festi D, Colecchia A, Renzulli M. Clinical impact of sarcopenia assessment in patients with liver cirrhosis. Expert Rev Gastroenterol Hepatol 2021;15:377-88. [PMID: 33196344 DOI: 10.1080/17474124.2021.1848542] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
71 Lee J, Jeong WK, Kim JH, Kim JM, Kim TY, Choi GS, Kwon CHD, Joh JW, Eom SY. Serial Observations of Muscle and Fat Mass as Prognostic Factors for Deceased Donor Liver Transplantation. Korean J Radiol 2021;22:189-97. [PMID: 33236536 DOI: 10.3348/kjr.2019.0750] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
72 Pita A, Ziogas IA, Ye F, Chen Y, Rauf MA, Matsuoka LK, Kaur N, Whang G, Zielsdorf SM, Bastas G, Izzy M, Alexopoulos SP. Feasibility of Serial Ultrasound Measurements of the Rectus Femoris Muscle Area to Assess Muscle Loss in Patients Awaiting Liver Transplantation in the Intensive Care Unit. Transplant Direct 2020;6:e618. [PMID: 33134494 DOI: 10.1097/TXD.0000000000001067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
73 Rozenberg D, Orsso CE, Chohan K, Orchanian‐cheff A, Nourouzpour S, Nicholson JM, Elangeswaran B, Vagaon A, Fidler L, Singer LG, Mathur S. Clinical outcomes associated with computed tomography‐based body composition measures in lung transplantation: a systematic review. Transpl Int 2020;33:1610-25. [DOI: 10.1111/tri.13749] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
74 Brandman D. Obesity Management of Liver Transplant Waitlist Candidates and Recipients. Clin Liver Dis 2021;25:1-18. [PMID: 33978572 DOI: 10.1016/j.cld.2020.08.001] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
75 Feng Z, Zhao H, Jiang Y, He Z, Sun X, Rong P, Wang W. Sarcopenia associates with increased risk of hepatocellular carcinoma among male patients with cirrhosis. Clinical Nutrition 2020;39:3132-9. [DOI: 10.1016/j.clnu.2020.01.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
76 Melchor SJ, Hatter JA, Castillo ÉAL, Saunders CM, Byrnes KA, Sanders I, Abebayehu D, Barker TH, Ewald SE. T. gondii infection induces IL-1R dependent chronic cachexia and perivascular fibrosis in the liver and skeletal muscle. Sci Rep 2020;10:15724. [PMID: 32973293 DOI: 10.1038/s41598-020-72767-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
77 Vugts JJA, Gaspersz MP, Roos E, Franken LC, Olthof PB, Coelen RJS, van Vugt JLA, Labeur TA, Brouwer L, Besselink MGH, IJzermans JNM, Darwish Murad S, van Gulik TM, de Jonge J, Polak WG, Busch ORC, Erdmann JL, Groot Koerkamp B, Buettner S. Eligibility for Liver Transplantation in Patients with Perihilar Cholangiocarcinoma.Ann Surg Oncol. 2021;28:1483-1492. [PMID: 32901308 DOI: 10.1245/s10434-020-09001-8] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
78 Ruiz-Margáin A, Xie JJ, Román-Calleja BM, Pauly M, White MG, Chapa-Ibargüengoitia M, Campos-Murguía A, González-Regueiro JA, Macias-Rodríguez RU, Duarte-Rojo A. Phase Angle From Bioelectrical Impedance for the Assessment of Sarcopenia in Cirrhosis With or Without Ascites. Clin Gastroenterol Hepatol 2021;19:1941-1949.e2. [PMID: 32890753 DOI: 10.1016/j.cgh.2020.08.066] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
79 Boutin RD, Lenchik L. Value-Added Opportunistic CT: Insights Into Osteoporosis and Sarcopenia. American Journal of Roentgenology 2020;215:582-94. [DOI: 10.2214/ajr.20.22874] [Cited by in Crossref: 13] [Cited by in F6Publishing: 21] [Article Influence: 6.5] [Reference Citation Analysis]
80 Marasco G, Serenari M, Renzulli M, Alemanni LV, Rossini B, Pettinari I, Dajti E, Ravaioli F, Golfieri R, Cescon M, Festi D, Colecchia A. Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments. J Gastroenterol 2020;55:927-43. [PMID: 32748172 DOI: 10.1007/s00535-020-01711-w] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 13.0] [Reference Citation Analysis]
81 Ohara M, Suda G, Kimura M, Maehara O, Shimazaki T, Shigesawa T, Suzuki K, Nakamura A, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N. Computed tomography, not bioelectrical impedance analysis, is the proper method for evaluating changes in skeletal muscle mass in liver disease. JCSM Rapid Communications 2020;3:103-14. [DOI: 10.1002/rco2.20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
82 Ebadi M, Bhanji RA, Tandon P, Mazurak V, Baracos VE, Montano-Loza AJ. Review article: prognostic significance of body composition abnormalities in patients with cirrhosis. Aliment Pharmacol Ther 2020;52:600-18. [PMID: 32621329 DOI: 10.1111/apt.15927] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
83 Esser H, Resch T, Pamminger M, Mutschlechner B, Troppmair J, Riedmann M, Gassner E, Maglione M, Margreiter C, Boesmueller C, Oberhuber R, Weissenbacher A, Cardini B, Finkenstedt A, Zoller H, Tilg H, Öfner D, Schneeberger S. Preoperative Assessment of Muscle Mass Using Computerized Tomography Scans to Predict Outcomes Following Orthotopic Liver Transplantation. Transplantation 2019;103:2506-14. [PMID: 30985737 DOI: 10.1097/TP.0000000000002759] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
84 Woodward AJ, Avery A, Keating SE, Ward LC, Coombes JS, Macdonald GA. Computerised tomography skeletal muscle and adipose surface area values in a healthy Caucasian population. Eur J Clin Nutr 2020;74:1276-81. [PMID: 32327731 DOI: 10.1038/s41430-020-0628-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
85 Lenchik L, Lenoir KM, Tan J, Boutin RD, Callahan KE, Kritchevsky SB, Wells BJ. Opportunistic Measurement of Skeletal Muscle Size and Muscle Attenuation on Computed Tomography Predicts 1-Year Mortality in Medicare Patients. J Gerontol A Biol Sci Med Sci 2019;74:1063-9. [PMID: 30124775 DOI: 10.1093/gerona/gly183] [Cited by in Crossref: 21] [Cited by in F6Publishing: 30] [Article Influence: 10.5] [Reference Citation Analysis]
86 Dhaliwal A, Williams FR, El-sherif O, Armstrong MJ. Sarcopenia in Liver Transplantation: an Update. Curr Hepatology Rep 2020;19:128-37. [DOI: 10.1007/s11901-020-00515-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Barbero-Becerra VJ, López-Méndez I, Romo-Araiza A, Visag-Castillo V, Chávez-Tapia NC, Uribe M, Juárez-Hernandez E. Sarcopenia in chronic liver diseases: a translational overview. Expert Rev Gastroenterol Hepatol 2020;14:355-66. [PMID: 32299261 DOI: 10.1080/17474124.2020.1757427] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
88 Oey RC, Aarts P, Erler NS, Metselaar HJ, Lakenman PL, Riemslag Baas-van der Ree S, van Kemenade MC, van Buuren HR, de Man RA. Identification and prognostic impact of malnutrition in a population screened for liver transplantation. Clinical Nutrition ESPEN 2020;36:36-44. [DOI: 10.1016/j.clnesp.2020.02.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
89 Sanchez-rodriguez D, Marco E, Cruz-jentoft AJ. Defining sarcopenia: some caveats and challenges. Current Opinion in Clinical Nutrition and Metabolic Care 2020;23:127-32. [DOI: 10.1097/mco.0000000000000621] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
90 Tsukagoshi M, Yokobori T, Yajima T, Maeno T, Shimizu K, Mogi A, Araki K, Harimoto N, Shirabe K, Kaira K. Skeletal muscle mass predicts the outcome of nivolumab treatment for non-small cell lung cancer. Medicine (Baltimore) 2020;99:e19059. [PMID: 32049805 DOI: 10.1097/MD.0000000000019059] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
91 Traub J, Bergheim I, Eibisberger M, Stadlbauer V. Sarcopenia and Liver Cirrhosis-Comparison of the European Working Group on Sarcopenia Criteria 2010 and 2019. Nutrients. 2020;12:547. [PMID: 32093198 DOI: 10.3390/nu12020547] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
92 Cabo SN, León Díaz FJ, Segura JS, Muñoz DC, Pérez BS, Montiel Casado MC, Pérez Daga JA, Narváez JA, Fernández Aguilar JL, Suárez Muñoz MA, Santoyo JS. Influence of Preoperative Muscle Mass Assessed by Computed Tomography on Prognosis After Liver Transplantation. Transplant Proc 2020;52:537-9. [PMID: 32037067 DOI: 10.1016/j.transproceed.2020.01.001] [Reference Citation Analysis]
93 Alconchel F, Martínez-Alarcón L, Nicolás-López T, Khiri F, Febrero B, Cascales-Campos PA, Martínez-Insfran LA, Ríos A, Fernández-Hernández JA, Rodríguez JM, López-López V, Sánchez-Bueno F, Robles-Campos R, Parrilla P, Ramírez P. Psoas Muscle Index Does Not Predict Post-Transplant Outcomes: A Series of 57 Liver Transplant Recipients. Transplant Proc 2020;52:549-52. [PMID: 32029312 DOI: 10.1016/j.transproceed.2019.12.032] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
94 Lurz E, Patel H, Lebovic G, Quammie C, Woolfson JP, Perez M, Ricciuto A, Wales PW, Kamath BM, Chavhan GB, Jüni P, Ng VL. Paediatric reference values for total psoas muscle area. J Cachexia Sarcopenia Muscle 2020;11:405-14. [PMID: 31920002 DOI: 10.1002/jcsm.12514] [Cited by in Crossref: 21] [Cited by in F6Publishing: 30] [Article Influence: 10.5] [Reference Citation Analysis]
95 Mazumder N, Rinella M. Editorial: sarcopenia in liver transplantation-our weakest patients may need the strongest push. Aliment Pharmacol Ther 2019;49:1100-1. [PMID: 30920044 DOI: 10.1111/apt.15204] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
96 Shenvi SD, Taber DJ, Hardie AD, Botstein JO, Mcgillicuddy JW. Assessment of magnetic resonance imaging derived fat fraction as a sensitive and reliable predictor of myosteatosis in liver transplant recipients. HPB 2020;22:102-8. [DOI: 10.1016/j.hpb.2019.06.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
97 Kumar V, Benjamin J, Shasthry V, Subramanya Bharathy KG, Sinha PK, Kumar G, Pamecha V. Sarcopenia in Cirrhosis: Fallout on Liver Transplantation. J Clin Exp Hepatol 2020;10:467-76. [PMID: 33029056 DOI: 10.1016/j.jceh.2019.12.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
98 Georgiou A, Papatheodoridis GV, Alexopoulou A, Deutsch M, Vlachogiannakos I, Ioannidou P, Papageorgiou MV, Papadopoulos N, Yannakoulia M, Kontogianni MD. Validation of cutoffs for skeletal muscle mass index based on computed tomography analysis against dual energy X-ray absorptiometry in patients with cirrhosis: the KIRRHOS study. Ann Gastroenterol. 2020;33:80-86. [PMID: 31892802 DOI: 10.20524/aog.2019.0432] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
99 Bunchorntavakul C, Reddy KR. Review article: malnutrition/sarcopenia and frailty in patients with cirrhosis. Aliment Pharmacol Ther 2020;51:64-77. [PMID: 31701570 DOI: 10.1111/apt.15571] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 18.3] [Reference Citation Analysis]
100 Raveh Y, Livingstone J, Mahan J, Tekin A, Selvaggi G, Bowdon‐romero M, Nicolau‐raducu R. Comprehensive Frailty Severity Index for End‐Stage Liver Disease Predicts Early Outcomes After Liver Transplantation. Journal of Parenteral and Enteral Nutrition 2020;44:1079-88. [DOI: 10.1002/jpen.1729] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
101 Ebadi M, Montano-loza AJ. Clinical relevance of skeletal muscle abnormalities in patients with cirrhosis. Digestive and Liver Disease 2019;51:1493-9. [DOI: 10.1016/j.dld.2019.05.034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
102 Aby ES, Saab S. Frailty, Sarcopenia, and Malnutrition in Cirrhotic Patients. Clinics in Liver Disease 2019;23:589-605. [DOI: 10.1016/j.cld.2019.06.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
103 Carey EJ, Lai JC, Sonnenday C, Tapper EB, Tandon P, Duarte-Rojo A, Dunn MA, Tsien C, Kallwitz ER, Ng V, Dasarathy S, Kappus M, Bashir MR, Montano-Loza AJ. A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation. Hepatology 2019;70:1816-29. [PMID: 31220351 DOI: 10.1002/hep.30828] [Cited by in Crossref: 108] [Cited by in F6Publishing: 99] [Article Influence: 36.0] [Reference Citation Analysis]
104 Ney M, Li S, Vandermeer B, Gramlich L, Ismond KP, Raman M, Tandon P. Systematic review with meta-analysis: Nutritional screening and assessment tools in cirrhosis. Liver Int. 2020;40:664-673. [PMID: 31571398 DOI: 10.1111/liv.14269] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
105 Ma KF, Berends B, Vedder IR, Levolger S, Gupta M, Schuurmann RC, de Vries JPPM, Bokkers RP. Quantification of muscle mass in the legs of patients with peripheral arterial occlusive disease: associations between volumetric and cross-sectional single-slice measurements for identification of atrophy and focal sarcopenia. J Cardiovasc Surg (Torino) 2019;60:672-8. [PMID: 31603293 DOI: 10.23736/S0021-9509.19.11107-X] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
106 Aby ES, Lee E, Saggi SS, Viramontes MR, Grotts JF, Agopian VG, Busuttil RW, Saab S. Pretransplant Sarcopenia in Patients With NASH Cirrhosis Does Not Impact Rehospitalization or Mortality. Journal of Clinical Gastroenterology 2019;53:680-5. [DOI: 10.1097/mcg.0000000000001109] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
107 Hari A, Berzigotti A, Štabuc B, Caglevič N. Muscle psoas indices measured by ultrasound in cirrhosis - Preliminary evaluation of sarcopenia assessment and prediction of liver decompensation and mortality. Dig Liver Dis 2019;51:1502-7. [PMID: 31547952 DOI: 10.1016/j.dld.2019.08.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
108 Ratnayake CBB, Wells C, Olsson M, Windsor JA, Pandanaboyana S. Sarcopenic obesity and post‐operative morbidity after pancreatic surgery: a cohort study. ANZ Journal of Surgery 2018;89:1587-92. [DOI: 10.1111/ans.15431] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
109 Paternostro R, Lampichler K, Bardach C, Asenbaum U, Landler C, Bauer D, Mandorfer M, Schwarzer R, Trauner M, Reiberger T, Ferlitsch A. The value of different CT-based methods for diagnosing low muscle mass and predicting mortality in patients with cirrhosis. Liver Int. 2019;39:2374-2385. [PMID: 31421002 DOI: 10.1111/liv.14217] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 5.7] [Reference Citation Analysis]
110 Kang SH, Jeong WK, Baik SK, Cha SH, Kim MY. Impact of sarcopenia on prognostic value of cirrhosis: Going beyond the hepatic venous pressure gradient and MELD score. J Cachexia Sarcopenia Muscle. 2018;9:860-870. [PMID: 30371017 DOI: 10.1002/jcsm.12333] [Cited by in Crossref: 32] [Cited by in F6Publishing: 48] [Article Influence: 10.7] [Reference Citation Analysis]
111 Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, Yagi S, Kamo N, Uemoto S. Including body composition in MELD scores improves mortality prediction among patients awaiting liver transplantation. Clin Nutr 2020;39:1885-92. [PMID: 31481263 DOI: 10.1016/j.clnu.2019.08.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
112 Vidot H, Kline K, Cheng R, Finegan L, Lin A, Kempler E, Strasser SI, Bowen DG, McCaughan GW, Carey S, Allman-Farinelli M, Shackel NA. The Relationship of Obesity, Nutritional Status and Muscle Wasting in Patients Assessed for Liver Transplantation. Nutrients. 2019;11. [PMID: 31487854 DOI: 10.3390/nu11092097] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
113 Janaudis-ferreira T, Mathur S, Deliva R, Howes N, Patterson C, Räkel A, So S, Wickerson L, White M, Avitzur Y, Johnston O, Heywood N, Singh S, Holdsworth S. Exercise for Solid Organ Transplant Candidates and Recipients: A Joint Position Statement of the Canadian Society of Transplantation and CAN-RESTORE. Transplantation 2019;103:e220-38. [DOI: 10.1097/tp.0000000000002806] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 4.7] [Reference Citation Analysis]
114 Barman PM, Patel YA. Getting a "Grip" on Sarcopenia for the Liver Transplant Candidate: Time to Focus on Muscle Function. Liver Transpl 2019;25:1475-6. [PMID: 31433898 DOI: 10.1002/lt.25625] [Reference Citation Analysis]
115 Parker R, Kim SJ, Im GY, Nahas J, Dhesi B, Vergis N, Sinha A, Ghezzi A, Rink MR, McCune A, Aithal GP, Newsome PN, Weston CJ, Holt A, Gao B. Obesity in acute alcoholic hepatitis increases morbidity and mortality. EBioMedicine 2019;45:511-8. [PMID: 31278069 DOI: 10.1016/j.ebiom.2019.03.046] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
116 Dong ZJ, Zhang HL, Yin LX. Effects of intradialytic resistance exercise on systemic inflammation in maintenance hemodialysis patients with sarcopenia: a randomized controlled trial. Int Urol Nephrol 2019;51:1415-24. [PMID: 31270740 DOI: 10.1007/s11255-019-02200-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 25] [Article Influence: 5.3] [Reference Citation Analysis]
117 Xia W, Barazanchi AWH, MacFater WS, Hill AG. The impact of computed tomography-assessed sarcopenia on outcomes for trauma patients - a systematic review and meta-analysis. Injury 2019;50:1565-76. [PMID: 31280971 DOI: 10.1016/j.injury.2019.07.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
118 Anastácio LR, Ferreira SC. Nutrition, dietary intake, and eating behavior after liver transplantation. Curr Opin Clin Nutr Metab Care 2018;21:381-7. [PMID: 29927763 DOI: 10.1097/MCO.0000000000000491] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
119 Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S. Combined Albumin-Bilirubin Grade and Skeletal Muscle Mass as a Predictor in Liver Cirrhosis. J Clin Med 2019;8:E782. [PMID: 31159435 DOI: 10.3390/jcm8060782] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
120 Chapman B, Gow P, Sinclair M, Hanrahan T, Angus P, McClure T, Mills C, Terbah R, Testro A. Continuous terlipressin infusion is associated with improved diet intake and muscle strength in patients awaiting liver transplant. JHEP Rep 2019;1:107-13. [PMID: 32039358 DOI: 10.1016/j.jhepr.2019.05.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
121 Artru F, Samuel D. Approaches for patients with very high MELD scores. JHEP Reports 2019;1:53-65. [DOI: 10.1016/j.jhepr.2019.02.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
122 Jahangiri Y, Pathak P, Tomozawa Y, Li L, Schlansky BL, Farsad K. Muscle Gain after Transjugular Intrahepatic Portosystemic Shunt Creation: Time Course and Prognostic Implications for Survival in Cirrhosis. J Vasc Interv Radiol. 2019;30:866-872.e4. [PMID: 31053265 DOI: 10.1016/j.jvir.2019.01.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
123 Moctezuma-Velázquez C, Low G, Mourtzakis M, Ma M, Burak KW, Tandon P, Montano-Loza AJ. Association between Low Testosterone Levels and Sarcopenia in Cirrhosis: A Cross-sectional Study. Ann Hepatol 2018;17:615-23. [PMID: 29893704 DOI: 10.5604/01.3001.0012.0930] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 5.7] [Reference Citation Analysis]
124 Thiberge C, Charpentier C, Gillibert A, Modzelewski R, Dacher JN, Savoye G, Savoye-Collet C. Lower Subcutaneous or Visceral Adiposity Assessed by Abdominal Computed Tomography Could Predict Adverse Outcome in Patients With Crohn's Disease. J Crohns Colitis. 2018;12:1429-1437. [PMID: 30260374 DOI: 10.1093/ecco-jcc/jjy124] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
125 Nattenmüller J, Schlett CL, Tsuchiya N, Reeder SB, Pickhardt PJ, Kramer H, Kauczor H, Wielpütz MO, Seo JB, Hatabu H, van Beek EJ, Schiebler ML. Noncontrast Chest Computed Tomographic Imaging of Obesity and the Metabolic Syndrome: Part II Noncardiovascular Findings. Journal of Thoracic Imaging 2019;34:126-35. [DOI: 10.1097/rti.0000000000000393] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
126 Nachit M, Leclercq I. Emerging awareness on the importance of skeletal muscle in liver diseases: time to dig deeper into mechanisms! Clinical Science 2019;133:465-81. [DOI: 10.1042/cs20180421] [Cited by in Crossref: 22] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
127 Eslamparast T, Vandermeer B, Raman M, Gramlich L, Den Heyer V, Belland D, Ma M, Tandon P. Are Predictive Energy Expenditure Equations Accurate in Cirrhosis? Nutrients 2019;11:E334. [PMID: 30720726 DOI: 10.3390/nu11020334] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
128 Montgomery J, Englesbe M. Sarcopenia in Liver Transplantation. Curr Transplant Rep 2019;6:7-15. [PMID: 31595213 DOI: 10.1007/s40472-019-0223-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
129 Wells CI, Mccall JL, Plank LD. Relationship Between Total Body Protein and Cross‐Sectional Skeletal Muscle Area in Liver Cirrhosis Is Influenced by Overhydration. Liver Transpl 2019;25:45-55. [DOI: 10.1002/lt.25314] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
130 Kobashigawa J, Dadhania D, Bhorade S, Adey D, Berger J, Bhat G, Budev M, Duarte-Rojo A, Dunn M, Hall S, Harhay MN, Johansen KL, Joseph S, Kennedy CC, Kransdorf E, Lentine KL, Lynch RJ, McAdams-DeMarco M, Nagai S, Olymbios M, Patel J, Pinney S, Schaenman J, Segev DL, Shah P, Singer LG, Singer JP, Sonnenday C, Tandon P, Tapper E, Tullius SG, Wilson M, Zamora M, Lai JC. Report from the American Society of Transplantation on frailty in solid organ transplantation. Am J Transplant 2019;19:984-94. [PMID: 30506632 DOI: 10.1111/ajt.15198] [Cited by in Crossref: 100] [Cited by in F6Publishing: 95] [Article Influence: 25.0] [Reference Citation Analysis]
131 Dasarathy S. Myostatin and beyond in cirrhosis: All roads lead to sarcopenia. J Cachexia Sarcopenia Muscle. 2017;8:864-869. [PMID: 29168629 DOI: 10.1002/jcsm.12262] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 7.5] [Reference Citation Analysis]
132 Engelmann C, Schob S, Nonnenmacher I, Werlich L, Aehling N, Ullrich S, Kaiser T, Krohn S, Herber A, Sucher R, Bartels M, Surov A, Hasenclever D, Kahn T, Seehofer D, Moche M, Berg T. Loss of paraspinal muscle mass is a gender-specific consequence of cirrhosis that predicts complications and death. Aliment Pharmacol Ther 2018;48:1271-81. [DOI: 10.1111/apt.15026] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
133 Tandon P, Ismond KP, Riess K, Duarte-rojo A, Al-judaibi B, Dunn MA, Holman J, Howes N, Haykowsky MJF, Josbeno DA, Mcneely M. Exercise in cirrhosis: Translating evidence and experience to practice. Journal of Hepatology 2018;69:1164-77. [DOI: 10.1016/j.jhep.2018.06.017] [Cited by in Crossref: 65] [Cited by in F6Publishing: 75] [Article Influence: 16.3] [Reference Citation Analysis]
134 Jeong JY, Lim S, Sohn JH, Lee JG, Jun DW, Kim Y. Presence of Sarcopenia and Its Rate of Change Are Independently Associated with Long-term Mortality in Patients with Liver Cirrhosis. J Korean Med Sci. 2018;33:e299. [PMID: 30534029 DOI: 10.3346/jkms.2018.33.e299] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
135 Engelke K, Museyko O, Wang L, Laredo JD. Quantitative analysis of skeletal muscle by computed tomography imaging-State of the art. J Orthop Translat 2018;15:91-103. [PMID: 30533385 DOI: 10.1016/j.jot.2018.10.004] [Cited by in Crossref: 48] [Cited by in F6Publishing: 65] [Article Influence: 12.0] [Reference Citation Analysis]
136 Cawthon PM. Recent Progress in Sarcopenia Research: a Focus on Operationalizing a Definition of Sarcopenia. Curr Osteoporos Rep 2018;16:730-7. [DOI: 10.1007/s11914-018-0484-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
137 van Vugt JL, Coebergh van den Braak RR, Schippers HJ, Veen KM, Levolger S, de Bruin RW, Koek M, Niessen WJ, Ijzermans JN, Willemsen FE. Contrast-enhancement influences skeletal muscle density, but not skeletal muscle mass, measurements on computed tomography. Clinical Nutrition 2018;37:1707-14. [DOI: 10.1016/j.clnu.2017.07.007] [Cited by in Crossref: 42] [Cited by in F6Publishing: 61] [Article Influence: 10.5] [Reference Citation Analysis]
138 Ebadi M, Wang CW, Lai JC, Dasarathy S, Kappus MR, Dunn MA, Carey EJ, Montano-Loza AJ;  From the Fitness; Life Enhancement;  and Exercise in Liver Transplantation (FLEXIT) Consortium. Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis. J Cachexia Sarcopenia Muscle. 2018;9:1053-1062. [PMID: 30269421 DOI: 10.1002/jcsm.12349] [Cited by in Crossref: 47] [Cited by in F6Publishing: 60] [Article Influence: 11.8] [Reference Citation Analysis]
139 De Bandt JP, Jegatheesan P, Tennoune-El-Hafaia N. Muscle Loss in Chronic Liver Diseases: The Example of Nonalcoholic Liver Disease. Nutrients 2018;10:E1195. [PMID: 30200408 DOI: 10.3390/nu10091195] [Cited by in Crossref: 23] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
140 van Vugt JLA, van Putten Y, van der Kall IM, Buettner S, D'Ancona FCH, Dekker HM, Kimenai HJAN, de Bruin RWF, Warlé MC, IJzermans JNM. Estimated skeletal muscle mass and density values measured on computed tomography examinations in over 1000 living kidney donors. Eur J Clin Nutr 2019;73:879-86. [PMID: 30143785 DOI: 10.1038/s41430-018-0287-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
141 European Association for the Study of the Liver. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol. 2019;70:172-193. [PMID: 30144956 DOI: 10.1016/j.jhep.2018.06.024] [Cited by in Crossref: 207] [Cited by in F6Publishing: 252] [Article Influence: 51.8] [Reference Citation Analysis]
142 Ohara M, Ogawa K, Suda G, Kimura M, Maehara O, Shimazaki T, Suzuki K, Nakamura A, Umemura M, Izumi T, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ohnishi S, Sakamoto N. L-Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis. Hepatol Commun. 2018;2:906-918. [PMID: 30094402 DOI: 10.1002/hep4.1207] [Cited by in Crossref: 35] [Cited by in F6Publishing: 41] [Article Influence: 8.8] [Reference Citation Analysis]
143 Duarte-Rojo A, Ruiz-Margáin A, Montaño-Loza AJ, Macías-Rodríguez RU, Ferrando A, Kim WR. Exercise and physical activity for patients with end-stage liver disease: Improving functional status and sarcopenia while on the transplant waiting list. Liver Transpl 2018;24:122-39. [PMID: 29024353 DOI: 10.1002/lt.24958] [Cited by in Crossref: 73] [Cited by in F6Publishing: 89] [Article Influence: 18.3] [Reference Citation Analysis]
144 Derstine BA, Holcombe SA, Ross BE, Wang NC, Su GL, Wang SC. Skeletal muscle cutoff values for sarcopenia diagnosis using T10 to L5 measurements in a healthy US population. Sci Rep 2018;8:11369. [PMID: 30054580 DOI: 10.1038/s41598-018-29825-5] [Cited by in Crossref: 104] [Cited by in F6Publishing: 160] [Article Influence: 26.0] [Reference Citation Analysis]
145 Merli M, Durand F. Muscle mass vs. adipose tissue to predict outcome in cirrhosis: Which matters and in which patients? J Hepatol 2018;69:567-9. [PMID: 30122221 DOI: 10.1016/j.jhep.2018.06.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
146 Noguchi H, Miyasaka Y, Kaku K, Kurihara K, Nakamura U, Okabe Y, Ohtsuka T, Ishigami K, Nakamura M. Preoperative Muscle Volume Predicts Graft Survival After Pancreas Transplantation: A Retrospective Observational Cohort Study. Transplantation Proceedings 2018;50:1482-8. [DOI: 10.1016/j.transproceed.2018.03.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
147 Eslamparast T, Montano-loza AJ, Raman M, Tandon P. Sarcopenic obesity in cirrhosis-The confluence of 2 prognostic titans. Liver Int 2018;38:1706-17. [DOI: 10.1111/liv.13876] [Cited by in Crossref: 46] [Cited by in F6Publishing: 61] [Article Influence: 11.5] [Reference Citation Analysis]
148 Burra P, Giannini EG, Caraceni P, Ginanni Corradini S, Rendina M, Volpes R, Toniutto P. Specific issues concerning the management of patients on the waiting list and after liver transplantation. Liver Int 2018;38:1338-62. [PMID: 29637743 DOI: 10.1111/liv.13755] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
149 Gu DH, Kim MY, Seo YS, Kim SG, Lee HA, Kim TH, Jung YK, Kandemir A, Kim JH, An H, Yim HJ, Yeon JE, Byun KS, Um SH. Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis. Clin Mol Hepatol. 2018;24:319-330. [PMID: 29706058 DOI: 10.3350/cmh.2017.0077] [Cited by in Crossref: 30] [Cited by in F6Publishing: 50] [Article Influence: 7.5] [Reference Citation Analysis]
150 Ebadi M, Tandon P, Moctezuma-Velazquez C, Ghosh S, Baracos VE, Mazurak VC, Montano-Loza AJ. Low subcutaneous adiposity associates with higher mortality in female patients with cirrhosis. J Hepatol. 2018;69:608-616. [PMID: 29709682 DOI: 10.1016/j.jhep.2018.04.015] [Cited by in Crossref: 49] [Cited by in F6Publishing: 61] [Article Influence: 12.3] [Reference Citation Analysis]
151 Lucidi C, Lattanzi B, Riggio O, Merli M. May sarcopenia and/or hepatic encephalopathy improve the predictivity of model for end-stage liver disease? J Hepatol 2018;68:1324-5. [PMID: 29627223 DOI: 10.1016/j.jhep.2018.02.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
152 Waclawski ER, Noone P. Systematic review: impact of liver transplantation on employment. Occup Med (Lond) 2018;68:88-95. [PMID: 29534206 DOI: 10.1093/occmed/kqy015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
153 Kok B, Tandon P. Frailty in Patients With Cirrhosis. Curr Treat Options Gastroenterol. 2018;16:215-225. [PMID: 29589278 DOI: 10.1007/s11938-018-0179-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
154 Kahn J, Wagner D, Homfeld N, Müller H, Kniepeiss D, Schemmer P. Both sarcopenia and frailty determine suitability of patients for liver transplantation-A systematic review and meta-analysis of the literature. Clin Transplant 2018;32:e13226. [DOI: 10.1111/ctr.13226] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
155 Carey E. Muscle mania: The enduring importance of muscle mass in liver disease. Liver Transpl 2018;24:585-6. [PMID: 29544032 DOI: 10.1002/lt.25054] [Reference Citation Analysis]
156 Borentain P, Rouabah K, Allard G, Ressiot E, Gerolami R. Letter: nutritional benefits of rifaximin in cirrhotic patients. Aliment Pharmacol Ther 2018;47:699-700. [PMID: 29417628 DOI: 10.1111/apt.14516] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
157 Carey EJ, Lai JC, Wang CW, Dasarathy S, Lobach I, Montano-Loza AJ, Dunn MA; Fitness, Life Enhancement, and Exercise in Liver Transplantation Consortium. A multicenter study to define sarcopenia in patients with end-stage liver disease. Liver Transpl. 2017;23:625-633. [PMID: 28240805 DOI: 10.1002/lt.24750] [Cited by in Crossref: 177] [Cited by in F6Publishing: 206] [Article Influence: 44.3] [Reference Citation Analysis]
158 van Vugt JLA, Gaspersz MP, Vugts J, Buettner S, Levolger S, de Bruin RWF, Polak WG, de Jonge J, Willemssen FEJA, Groot Koerkamp B, IJzermans JNM. Low Skeletal Muscle Density Is Associated with Early Death in Patients with Perihilar Cholangiocarcinoma Regardless of Subsequent Treatment. Dig Surg. 2019;36:144-152. [PMID: 29455204 DOI: 10.1159/000486867] [Cited by in Crossref: 13] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
159 Lurz E, Patel H, Frimpong RG, Ricciuto A, Kehar M, Wales PW, Towbin AJ, Chavhan GB, Kamath BM, Ng VL. Sarcopenia in Children With End-Stage Liver Disease. Journal of Pediatric Gastroenterology & Nutrition 2018;66:222-6. [DOI: 10.1097/mpg.0000000000001792] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 9.3] [Reference Citation Analysis]
160 Chang C, Wu JS, Mhuircheartaigh JN, Hochman MG, Rodriguez EK, Appleton PT, Mcmahon CJ. Effect of sarcopenia on clinical and surgical outcome in elderly patients with proximal femur fractures. Skeletal Radiol 2018;47:771-7. [DOI: 10.1007/s00256-017-2848-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
161 van Vugt JLA, Alferink LJM, Buettner S, Gaspersz MP, Bot D, Darwish Murad S, Feshtali S, van Ooijen PMA, Polak WG, Porte RJ, van Hoek B, van den Berg AP, Metselaar HJ, IJzermans JNM. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort. J Hepatol. 2018;68:707-714. [PMID: 29221886 DOI: 10.1016/j.jhep.2017.11.030] [Cited by in Crossref: 68] [Cited by in F6Publishing: 93] [Article Influence: 13.6] [Reference Citation Analysis]
162 Hammad A, Kaido T, Hamaguchi Y, Okumura S, Kobayashi A, Shirai H, Kamo N, Yagi S, Uemoto S. Impact of sarcopenic overweight on the outcomes after living donor liver transplantation. Hepatobiliary Surg Nutr. 2017;6:367-378. [PMID: 29312971 DOI: 10.21037/hbsn.2017.02.02] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
163 Anand AC. Nutrition and Muscle in Cirrhosis. J Clin Exp Hepatol. 2017;7:340-357. [PMID: 29234200 DOI: 10.1016/j.jceh.2017.11.001] [Cited by in Crossref: 54] [Cited by in F6Publishing: 67] [Article Influence: 10.8] [Reference Citation Analysis]
164 van Vugt JLA, Buettner S, Levolger S, Coebergh van den Braak RRJ, Suker M, Gaspersz MP, de Bruin RWF, Verhoef C, van Eijck CHC, Bossche N, Groot Koerkamp B, IJzermans JNM. Low skeletal muscle mass is associated with increased hospital expenditure in patients undergoing cancer surgery of the alimentary tract. PLoS One 2017;12:e0186547. [PMID: 29088245 DOI: 10.1371/journal.pone.0186547] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
165 Mazurak VC, Tandon P, Montano-loza AJ. Nutrition and the transplant candidate: Mazurak et al. Liver Transpl 2017;23:1451-64. [DOI: 10.1002/lt.24848] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
166 Kim G, Kang SH, Kim MY, Baik SK. Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis. PLoS One. 2017;12:e0186990. [PMID: 29065187 DOI: 10.1371/journal.pone.0186990] [Cited by in Crossref: 97] [Cited by in F6Publishing: 144] [Article Influence: 19.4] [Reference Citation Analysis]
167 van Vugt JLA, Buettner S, Alferink LJM, Bossche N, de Bruin RWF, Darwish Murad S, Polak WG, Metselaar HJ, Ijzermans JNM. Low skeletal muscle mass is associated with increased hospital costs in patients with cirrhosis listed for liver transplantation-a retrospective study. Transpl Int 2018;31:165-74. [DOI: 10.1111/tri.13048] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
168 Heard RSM, Ramsay G, Hildebrand DR. Sarcopaenia in surgical populations: A review. Surgeon 2017;15:366-71. [PMID: 28684167 DOI: 10.1016/j.surge.2017.06.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
169 Mathur S, Rodrigues N, Mendes P, Rozenberg D, Singer LG. Computed Tomography–Derived Thoracic Muscle Size as an Indicator of Sarcopenia in People With Advanced Lung Disease. Cardiopulm Phys Ther J 2017;28:99-105. [DOI: 10.1097/cpt.0000000000000054] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
170 Rozenberg D, Mathur S, Herridge M, Goldstein R, Schmidt H, Chowdhury NA, Mendes P, Singer LG. Thoracic muscle cross-sectional area is associated with hospital length of stay post lung transplantation: a retrospective cohort study. Transpl Int 2017;30:713-24. [PMID: 28390073 DOI: 10.1111/tri.12961] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
171 Nishikawa H, Enomoto H, Iwata Y, Nishimura T, Iijima H, Nishiguchi S. Clinical utility of bioimpedance analysis in liver cirrhosis. J Hepatobiliary Pancreat Sci 2017;24:409-16. [PMID: 28371518 DOI: 10.1002/jhbp.455] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
172 van Grinsven J, van Vugt JLA, Gharbharan A, Bollen TL, Besselink MG, van Santvoort HC, van Eijck CHJ, Boerma D; Dutch Pancreatitis Study Group. The Association of Computed Tomography-Assessed Body Composition with Mortality in Patients with Necrotizing Pancreatitis. J Gastrointest Surg 2017;21:1000-8. [PMID: 28299618 DOI: 10.1007/s11605-016-3352-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
173 Boutin RD, Bamrungchart S, Bateni CP, Beavers DP, Beavers KM, Meehan JP, Lenchik L. CT of Patients With Hip Fracture: Muscle Size and Attenuation Help Predict Mortality. AJR Am J Roentgenol 2017;208:W208-15. [PMID: 28267356 DOI: 10.2214/AJR.16.17226] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 7.8] [Reference Citation Analysis]
174 Kamiya K, Masuda T, Matsue Y, Hamazaki N, Matsuzawa R, Tanaka S, Nozaki K, Maekawa E, Noda C, Yamaoka-Tojo M, Matsunaga A, Ako J. Prognostic Usefulness of Arm and Calf Circumference in Patients ≥65 Years of Age With Cardiovascular Disease. Am J Cardiol 2017;119:186-91. [PMID: 27823596 DOI: 10.1016/j.amjcard.2016.09.040] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
175 Golse N, Bucur PO, Ciacio O, Pittau G, Sa Cunha A, Adam R, Castaing D, Antonini T, Coilly A, Samuel D, Cherqui D, Vibert E. A new definition of sarcopenia in patients with cirrhosis undergoing liver transplantation: GOLSE ET AL. Liver Transpl 2017;23:143-54. [DOI: 10.1002/lt.24671] [Cited by in Crossref: 79] [Cited by in F6Publishing: 90] [Article Influence: 15.8] [Reference Citation Analysis]
176 van Vugt JL, Levolger S, Gharbharan A, Koek M, Niessen WJ, Burger JW, Willemsen SP, de Bruin RW, IJzermans JN. A comparative study of software programmes for cross-sectional skeletal muscle and adipose tissue measurements on abdominal computed tomography scans of rectal cancer patients. J Cachexia Sarcopenia Muscle 2017;8:285-97. [PMID: 27897414 DOI: 10.1002/jcsm.12158] [Cited by in Crossref: 89] [Cited by in F6Publishing: 113] [Article Influence: 14.8] [Reference Citation Analysis]
177 Gani F, Buettner S, Margonis GA, Sasaki K, Wagner D, Kim Y, Hundt J, Kamel IR, Pawlik TM. Sarcopenia predicts costs among patients undergoing major abdominal operations. Surgery 2016;160:1162-71. [DOI: 10.1016/j.surg.2016.05.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 41] [Article Influence: 5.8] [Reference Citation Analysis]
178 Dasarathy S, Merli M. Sarcopenia from mechanism to diagnosis and treatment in liver disease. J Hepatol. 2016;65:1232-1244. [PMID: 27515775 DOI: 10.1016/j.jhep.2016.07.040] [Cited by in Crossref: 235] [Cited by in F6Publishing: 269] [Article Influence: 39.2] [Reference Citation Analysis]
179 Tandon P, Mourtzakis M. Reply. Clin Gastroenterol Hepatol 2016;14:1672. [PMID: 27449403 DOI: 10.1016/j.cgh.2016.07.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
180 Tandon P, Mourtzakis M, Low G, Zenith L, Ney M, Carbonneau M, Alaboudy A, Mann S, Esfandiari N, Ma M. Comparing the Variability Between Measurements for Sarcopenia Using Magnetic Resonance Imaging and Computed Tomography Imaging. Am J Transplant 2016;16:2766-7. [DOI: 10.1111/ajt.13832] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
181 Tandon P, Low G, Mourtzakis M, Zenith L, Myers RP, Abraldes JG, Shaheen AA, Qamar H, Mansoor N, Carbonneau M, Ismond K, Mann S, Alaboudy A, Ma M. A Model to Identify Sarcopenia in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2016;14:1473-1480.e3. [PMID: 27189915 DOI: 10.1016/j.cgh.2016.04.040] [Cited by in Crossref: 111] [Cited by in F6Publishing: 105] [Article Influence: 18.5] [Reference Citation Analysis]